SLÁMA, J., P. DUNDR, Ladislav DUŠEK, D. FISCHEROVÁ, I. PINKAVOVÁ, M. ZIKAN, P. VRZACKOVA, M. KOJANOVA a D. CIBULA. Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy. Gynecologic Oncology. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2012, roč. 125, č. 2, s. 303-306. ISSN 0090-8258. Dostupné z: https://dx.doi.org/10.1016/j.ygyno.2012.02.010.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy
Autoři SLÁMA, J. (203 Česká republika, garant), P. DUNDR (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí), D. FISCHEROVÁ (203 Česká republika), I. PINKAVOVÁ (203 Česká republika), M. ZIKAN (203 Česká republika), P. VRZACKOVA (203 Česká republika), M. KOJANOVA (203 Česká republika) a D. CIBULA (203 Česká republika).
Vydání Gynecologic Oncology, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2012, 0090-8258.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30214 Obstetrics and gynaecology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.929
Kód RIV RIV/00216224:14110/12:00060412
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.ygyno.2012.02.010
UT WoS 000303227500005
Klíčová slova anglicky Cervical cancer; Sentinel lymph node; Neoadjuvant chemotherapy; Radical hysterectomy
Příznaky Mezinárodní význam
Změnil Změnil: Mgr. Michal Petr, učo 65024. Změněno: 17. 7. 2012 08:48.
Anotace
Objectives. Neoadjuvant chemotherapy (NAC) is used in locally advanced cervical cancers with the aim to decrease the size of the tumor and to allow for less radical surgery. Despite of the fact that the high response rate of the tumor has been well established, the impact of NAC on sentinel lymph node (SN) detection and status has not been explored to date. Methods. Our study included 82 patients with locally advanced cervical cancers (FIGO IB1 >3 cm, IB2, IIA2 and selected IIB) out of which 51 patients were referred to SN biopsy prior to NAC and 31 patients to radical surgical procedure including SN biopsy after three courses of "dose density" NAC. In both groups, the prevalence of macrometastases, micrometastases and isolated tumor cells (ITC) in SN was compared. Results. The total of 179 SNs was evaluated. SN detection rate in the whole cohort reached 87.8% per patient and 60.9% bilaterally, without significant difference between both groups. In the group with upfront SN biopsy prior to NAC the prevalence of macrometastases, micrometastases and ITC amounted to 43.1% (22/51), 7.8% (4/51) and 7.8% (4/51) respectively. In the group with SN biopsy after previous NAC, macrometastases were detected in 22.6 (7/31) of patients in SN, whereas there was only one micrometastasis and no ITC detected in that group. Conclusions. Neoadjuvant chemotherapy did not influence the detection rate of SNs, yet it was associated with significantly reduced prevalence of metastatic involvement of SNs, especially almost completely eliminating low volume disease.
VytisknoutZobrazeno: 19. 9. 2024 11:05